Anti-CD8 alpha antibody [CAL38]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0457591-V3
- Awardee
- Epitomics Inc
- Contracting organization
- University of Virginia
- Cumulative value
- $470.25
About this award
The University of Virginia awarded contract A207_PO-0457591-V3 to Epitomics Inc on September 26, 2026, for the supply of Anti-CD8 alpha antibody [CAL38], a monoclonal antibody reagent utilized in immunological research and diagnostics. The contract specifies delivery of 470 units at a unit price of $1 per unit, resulting in a total contract value of $470. Delivery is designated to the buyer, with performance taking place in Virginia.
This procurement represents a straightforward materials supply agreement for laboratory reagents required by the University of Virginia's research operations. As the prime contractor, Epitomics Inc is responsible for fulfilling the complete order of Anti-CD8 alpha antibody [CAL38] units within the terms established by the contracting organization. The contract documents do not specify an explicit performance period; however, the award date of September 26, 2026, serves as the reference point for contract initiation.
Line items
| Item | Total |
|---|---|
| Anti-CD8 alpha antibody [CAL38] | $470.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0457591-V3?
Contract A207_PO-0457591-V3 was awarded to Epitomics Inc by University of Virginia on September 26, 2026.
How much is contract A207_PO-0457591-V3 worth?
Its cumulative value is $470.25.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award